Summary

The global Covered Esophageal Stent market is projected to grow from US$ 302 million in 2025 to US$ 471 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Covered Esophageal Stent refers to a covered endoluminal implant designed to restore esophageal patency, prevent tissue ingrowth or seal defects in the esophageal wall. The market is dominated by self-expanding metal stents manufactured from braided nitinol wire or laser-cut nitinol tubing and covered with silicone, polyurethane, expanded polytetrafluoroethylene or comparable medical polymers. Products are supplied preloaded in endoscopic or fluoroscopic delivery systems and are principally classified as fully covered and partially covered esophageal stents. Functional designs may incorporate flared ends, anti-migration struts, retrieval sutures, anti-reflux valves, double-layer meshes or specialized cervical configurations. Key specifications include stent body and flange diameter, covered and overall length, delivery-system profile, radial and axial force, shortening ratio, conformability, radiopacity, covering integrity, migration resistance, repositionability and removability. Principal applications include malignant esophageal strictures and dysphagia, refractory benign esophageal strictures, esophagorespiratory fistulas, postoperative leaks and esophageal perforations.
Key Findings
In 2025, global Covered Esophageal Stent production reached approximately 193 K Units, with an average global market price of around US$ 1,565 per unit.
Covered nitinol SEMS constitute the principal product platform within the target market
Fully covered products support sealing and retrieval but require stronger migration control
Malignant esophageal stricture remains the most established clinical application
Benign strictures, fistulas and perforations support temporary removable stent demand
Competition combines multinational platforms with specialized Korean, European and Chinese manufacturers
Market Trends
The market is evolving from general-purpose covered tubular stents toward indication-specific systems optimized for lesion location, esophageal anatomy and treatment duration. Manufacturers are seeking to provide sufficient radial force to open severe strictures while reducing axial force, flange stiffness and pressure on healthy tissue. Fully covered designs increasingly incorporate flared ends, anchoring fins, anti-migration struts, collars, double-layer meshes and proximal or distal retrieval sutures to combine stable fixation with safe removal. Lower-profile and through-the-scope delivery systems improve access through tight or tortuous stenoses and can enable deployment under direct endoscopic visualization. Specialized products are expanding, including soft-ended devices for cervical or proximal lesions, anti-reflux models for stents crossing the gastroesophageal junction, large-diameter configurations for postoperative leaks and perforations, and emergency stents for refractory esophageal variceal bleeding. Reduced foreshortening, controlled release, partial recapture and immediate repositioning are becoming important procurement criteria. Hospitals increasingly evaluate the complete clinical pathway, including placement accuracy, dwell-time management, migration monitoring, retrieval technique and adverse-event support, rather than assessing nominal stent specifications alone.
Market Dynamics
Drivers
Demand is principally driven by esophageal cancer and other malignancies that cause dysphagia through intrinsic tumor growth or external compression. Covered stents can rapidly restore oral intake, reduce tumor ingrowth and support palliative care, nutritional recovery and subsequent oncology treatment. Population aging and wider access to therapeutic endoscopy expand the eligible patient population. Advances in endoscopic imaging, fluoroscopic navigation, guidewires and delivery systems also allow physicians to manage tighter and more anatomically complex lesions. Refractory benign esophageal strictures create demand for temporary removable stents when repeated dilation has not provided durable relief. Clinical use is further supported by the role of fully covered products in sealing esophagorespiratory fistulas, postoperative anastomotic leaks and selected spontaneous or iatrogenic perforations. Multidisciplinary collaboration among gastroenterologists, thoracic surgeons, oncologists and interventional radiologists improves patient selection and facilitates standardized treatment pathways.
Restraints
Market adoption is constrained by stent migration, chest pain, gastroesophageal reflux, food impaction, bleeding, tissue overgrowth, recurrent dysphagia and perforation. Fully covered stents prevent tissue ingrowth and facilitate retrieval, but reduced integration with the esophageal wall can increase migration risk. Partially covered products achieve stronger anchoring through uncovered portions, although tissue embedding may complicate later removal. Clinical outcomes vary according to lesion position, stricture length, proximity to the upper esophageal sphincter or gastroesophageal junction, previous radiotherapy, stent diameter and operator experience. Balloon dilation, surgery, feeding-access procedures and other endoscopic therapies remain alternatives for selected patients. Commercialization is also affected by regional differences in indications, reimbursement and hospital procurement. Benign applications require strict dwell-time control, retrieval planning and follow-up, which limits use in institutions without experienced therapeutic-endoscopy teams.
Opportunities
Temporary management of refractory benign strictures, postoperative anastomotic leaks, esophageal fistulas and perforations represents a major opportunity for fully covered and reliably removable stents. Products combining low migration, atraumatic retrieval and predictable force distribution can broaden physician acceptance. Proximal and cervical lesions create demand for small-diameter, soft-ended devices, while distal lesions crossing the gastroesophageal junction support anti-reflux configurations. Through-the-scope systems offer potential in severe and tortuous stenoses by reducing delivery profile and enabling direct visualization. Large-diameter, high-sealing-force products can address postoperative leaks and spontaneous or iatrogenic ruptures. Specialized covered stents for temporary control of refractory esophageal variceal bleeding constitute a smaller but clinically differentiated segment. Emerging markets provide additional growth potential as cancer diagnosis and therapeutic-endoscopy capacity improve. Manufacturers can create value through indication-specific sizes, standardized placement and retrieval protocols, physician training, procedural accessories, local case support and prospective clinical evidence.
Challenges
The core engineering challenge is balancing radial expansion, axial flexibility, migration resistance and atraumatic contact with the esophageal wall. Excessive radial force may increase pain or pressure-related injury, while insufficient force can compromise patency or defect sealing. Aggressive anchoring structures may reduce migration but increase mucosal trauma or retrieval difficulty. Covering materials must withstand gastric acid exposure, food abrasion and repeated esophageal movement without tearing, delamination or loss of elasticity. Deployment accuracy can be affected by foreshortening, elongation, severe stenosis and delivery-catheter resistance. Clinical evidence is difficult to compare because malignant strictures, benign disease, fistulas and perforations have different treatment objectives, dwell times and follow-up periods. Manufacturers must maintain consistent nitinol properties, mesh geometry, membrane thickness, marker location, sterilization and delivery-system reliability. Design modifications or expanded indications can also trigger additional regulatory and clinical-validation requirements.
Industry Chain Analysis
The upstream chain comprises medical-grade nitinol wire or tubing, silicone, polyurethane and expanded polytetrafluoroethylene coverings, platinum-iridium or tantalum radiopaque markers, retrieval sutures, polymer catheters, guidewire-compatible components, sterilization services and precision manufacturing equipment. Production processes include wire braiding or laser cutting, heat setting, electropolishing, cleaning, membrane application, flange and anti-migration structure formation, marker assembly, delivery-system integration, packaging and sterilization validation. Midstream value is created through stent geometry, radial and axial force engineering, covering durability, migration control, deployment accuracy, repositioning or retrieval capability and batch consistency. Finished systems reach hospitals through direct sales organizations, endoscopy-platform companies and specialized distributors. Downstream users include gastroenterology departments, cancer centers, thoracic surgery units and interventional radiology teams. Commercial value extends beyond implant production to regulatory registration, clinical evidence, physician education, procedure support, inventory availability, traceability and post-market surveillance. Reliable retrieval devices and standardized management protocols are particularly important for temporary fully covered stents.
Segment Insights
By covering structure, fully covered and partially covered esophageal stents constitute the primary classification. Fully covered products use a polymer membrane across the entire stent body and generally over both ends, preventing tumor or granulation-tissue ingrowth and facilitating removal. Migration is their principal design limitation, leading manufacturers to incorporate flared ends, anchoring fins, anti-migration struts, collars, double-layer structures and retrieval sutures. Partially covered products retain uncovered sections, usually at one or both ends, to strengthen anchoring while using a covered central body to reduce tumor ingrowth. They are widely associated with malignant dysphagia but may become embedded when tissue grows through the uncovered mesh, increasing removal complexity.
Additional commercially relevant classifications include braided-wire versus laser-cut construction, silicone versus other polymer coverings, proximal versus distal release, over-the-wire versus through-the-scope deployment, and removable versus long-term palliative use. Functional variants include conventional, anti-reflux, cervical, low-radial-force, high-sealing-force and variceal-bleeding stents. By application, the initial structure of malignant esophageal stricture, benign esophageal stricture, esophageal fistula and perforation, and other indications is appropriate. The other category mainly covers postoperative anastomotic leakage, refractory esophageal variceal bleeding and specialized esophageal complications rather than unrelated gastrointestinal diseases.
Downstream Market Opportunities
Malignant esophageal stricture is the most established application because covered stents can restore swallowing and reduce tumor ingrowth in patients requiring palliation. Benign esophageal strictures constitute a selective market centered on refractory cases in which repeated dilation has failed and scheduled stent removal is feasible. Esophagorespiratory fistulas require dependable sealing to reduce aspiration, while postoperative anastomotic leaks and esophageal perforations demand sufficient covered length, membrane durability and positional stability. Stents crossing the gastroesophageal junction can benefit from anti-reflux valves, whereas cervical strictures require softer proximal ends and carefully selected diameters. Refractory esophageal variceal bleeding represents a specialized emergency application rather than a conventional stricture market. Suppliers offering indication-specific dimensions, retrieval systems, clinical protocols and physician training can access higher-value demand than manufacturers supplying undifferentiated covered stents.
Regional Insights
North America and Europe are mature markets with established oncology pathways, therapeutic-endoscopy infrastructure and stringent regulatory requirements. Boston Scientific, Cook Medical and Merit Medical Systems have broad commercial platforms and hospital access, while ELLA-CS, ENDO-FLEX, Leufen Medical and AndraTec provide specialized European products. Innovation focuses on removable fully covered systems, lower-profile delivery devices, migration prevention and evidence-supported management of benign strictures, fistulas and perforations. Approved indications differ between the United States, Europe and other jurisdictions, making regulatory portfolio management a significant competitive factor.
South Korea is an important specialist manufacturing base represented by M.I.Tech, Taewoong Medical and Sewoon Medical. Their portfolios cover diverse esophageal geometries, covering configurations, release systems and anti-reflux functions. Japan has a sophisticated endoscopy market and strong distribution capabilities; Olympus supplies selected HANAROSTENT esophageal products manufactured by M.I.Tech and should therefore be treated as a product provider and distributor rather than the independent manufacturing source of those devices. China is expanding through Micro-Tech Endoscopy, Jiangsu Vedkang, Changzhou Zhiye Medical Instrument Research Institute and Anrei Medical. Türkiye, India and other emerging production regions participate through INVAMED, Mitra Industries and additional regional suppliers, subject to product-level registration and current manufacturing verification.
Competitive Landscape Analysis
The market comprises multinational endoscopy companies, specialist covered-stent manufacturers and regional product providers. Boston Scientific supplies fully and partially covered WallFlex esophageal stents and competes through portfolio breadth, delivery-system control and international hospital access. Cook Medical offers the Evolution controlled-release platform, while Merit Medical Systems focuses on fully covered laser-cut products such as EndoMAXX and ALIMAXX-ES, emphasizing deployment accuracy, retrieval and anti-migration characteristics. M.I.Tech manufactures the HANAROSTENT esophageal line distributed by Olympus in the United States, meaning the two companies should not be counted as separate manufacturers for the relevant products. Taewoong Medical is an important omission from the initial list and should be added to the core enterprise pool; its Niti-S portfolio includes fully covered, double-layer, cervical and anti-reflux esophageal configurations. ELLA-CS differentiates through removable fully covered products, leak-sealing systems and the Danis stent for refractory variceal bleeding. Micro-Tech Endoscopy, ENDO-FLEX, Leufen Medical, Sewoon Medical, INVAMED, Jiangsu Vedkang, Changzhou Zhiye, Anrei Medical, AndraTec and Mitra Industries form the extended specialist pool. Competitive differentiation centers on force balance, migration control, membrane integrity, delivery profile, retrieval performance, regulatory coverage and physician support, and supplier rankings should not be inferred without comparable audited sales data.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Covered Esophageal Stent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Boston Scientific
Cook Medical
M.I.Tech
Merit Medical Systems
Olympus Corporation
ELLA-CS, s.r.o.
ENDO-FLEX GmbH
Leufen Medical
Micro-Tech Endoscopy
Anrei medical (hz)
Mitra Industries Private Limited
Sewoon Medical
INVAMED
Jiangsu Vedkang Medical Science and Technology
Changzhou Zhiye Medical Instrument Research Institute
AndraTec
Segment by Type
Fully Covered Esophageal Stent
Partially Covered Esophageal Stent
Segment by External Structure
Double Cup Mouth Cylindrical Mesh
Cup Mouth Ball Head Cylindrical Mesh
Segment by Diameter
Diameter 16 mm
Diameter 18 mm
Diameter 20 mm
Diameter 22 mm
Diameter 25 mm
Segment by Application
Malignant Esophageal Stricture
Benign Esophageal Stricture
Esophageal Fistula and Perforation
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Covered Esophageal Stent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Covered Esophageal Stent: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Covered Esophageal Stent Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Fully Covered Esophageal Stent
1.2.3 Partially Covered Esophageal Stent
1.3 Market Segmentation by External Structure
1.3.1 Global Covered Esophageal Stent Market Size by External Structure, 2021 vs 2025 vs 2032
1.3.2 Double Cup Mouth Cylindrical Mesh
1.3.3 Cup Mouth Ball Head Cylindrical Mesh
1.4 Market Segmentation by Diameter
1.4.1 Global Covered Esophageal Stent Market Size by Diameter, 2021 vs 2025 vs 2032
1.4.2 Diameter 16 mm
1.4.3 Diameter 18 mm
1.4.4 Diameter 20 mm
1.4.5 Diameter 22 mm
1.4.6 Diameter 25 mm
1.5 Market Segmentation by Application
1.5.1 Global Covered Esophageal Stent Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Malignant Esophageal Stricture
1.5.3 Benign Esophageal Stricture
1.5.4 Esophageal Fistula and Perforation
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Covered Esophageal Stent Revenue Estimates and Forecasts (2021-2032)
2.2 Global Covered Esophageal Stent Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Covered Esophageal Stent Sales Estimates and Forecasts (2021-2032)
2.4 Global Covered Esophageal Stent Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Covered Esophageal Stent Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Covered Esophageal Stent Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Fully Covered Esophageal Stent: Market Share by Key Manufacturers
3.5.2 Partially Covered Esophageal Stent: Market Share by Key Manufacturers
3.6 Global Covered Esophageal Stent Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Covered Esophageal Stent Sales Performance by Type
4.1.1 Global Covered Esophageal Stent Sales Volume by Type (2021-2032)
4.1.2 Global Covered Esophageal Stent Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Covered Esophageal Stent Sales Performance by External Structure
4.2.1 Global Covered Esophageal Stent Sales Volume by External Structure (2021-2032)
4.2.2 Global Covered Esophageal Stent Revenue by External Structure (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by External Structure (2021-2032)
4.3 Global Covered Esophageal Stent Sales Performance by Diameter
4.3.1 Global Covered Esophageal Stent Sales Volume by Diameter (2021-2032)
4.3.2 Global Covered Esophageal Stent Revenue by Diameter (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Diameter (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Covered Esophageal Stent Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Covered Esophageal Stent Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Covered Esophageal Stent Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Covered Esophageal Stent Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Covered Esophageal Stent Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Covered Esophageal Stent Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Covered Esophageal Stent Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Covered Esophageal Stent Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Covered Esophageal Stent Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Covered Esophageal Stent Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Covered Esophageal Stent Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Covered Esophageal Stent Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Covered Esophageal Stent Product Models, Descriptions and Specifications
11.1.4 Boston Scientific Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Boston Scientific Covered Esophageal Stent Sales by Product in 2025
11.1.6 Boston Scientific Covered Esophageal Stent Sales by Application in 2025
11.1.7 Boston Scientific Covered Esophageal Stent Sales by Geographic Area in 2025
11.1.8 Boston Scientific Covered Esophageal Stent SWOT Analysis
11.1.9 Boston Scientific Recent Developments
11.2 Cook Medical
11.2.1 Cook Medical Corporation Information
11.2.2 Cook Medical Business Overview
11.2.3 Cook Medical Covered Esophageal Stent Product Models, Descriptions and Specifications
11.2.4 Cook Medical Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Cook Medical Covered Esophageal Stent Sales by Product in 2025
11.2.6 Cook Medical Covered Esophageal Stent Sales by Application in 2025
11.2.7 Cook Medical Covered Esophageal Stent Sales by Geographic Area in 2025
11.2.8 Cook Medical Covered Esophageal Stent SWOT Analysis
11.2.9 Cook Medical Recent Developments
11.3 M.I.Tech
11.3.1 M.I.Tech Corporation Information
11.3.2 M.I.Tech Business Overview
11.3.3 M.I.Tech Covered Esophageal Stent Product Models, Descriptions and Specifications
11.3.4 M.I.Tech Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 M.I.Tech Covered Esophageal Stent Sales by Product in 2025
11.3.6 M.I.Tech Covered Esophageal Stent Sales by Application in 2025
11.3.7 M.I.Tech Covered Esophageal Stent Sales by Geographic Area in 2025
11.3.8 M.I.Tech Covered Esophageal Stent SWOT Analysis
11.3.9 M.I.Tech Recent Developments
11.4 Merit Medical Systems
11.4.1 Merit Medical Systems Corporation Information
11.4.2 Merit Medical Systems Business Overview
11.4.3 Merit Medical Systems Covered Esophageal Stent Product Models, Descriptions and Specifications
11.4.4 Merit Medical Systems Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Merit Medical Systems Covered Esophageal Stent Sales by Product in 2025
11.4.6 Merit Medical Systems Covered Esophageal Stent Sales by Application in 2025
11.4.7 Merit Medical Systems Covered Esophageal Stent Sales by Geographic Area in 2025
11.4.8 Merit Medical Systems Covered Esophageal Stent SWOT Analysis
11.4.9 Merit Medical Systems Recent Developments
11.5 Olympus Corporation
11.5.1 Olympus Corporation Corporation Information
11.5.2 Olympus Corporation Business Overview
11.5.3 Olympus Corporation Covered Esophageal Stent Product Models, Descriptions and Specifications
11.5.4 Olympus Corporation Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Olympus Corporation Covered Esophageal Stent Sales by Product in 2025
11.5.6 Olympus Corporation Covered Esophageal Stent Sales by Application in 2025
11.5.7 Olympus Corporation Covered Esophageal Stent Sales by Geographic Area in 2025
11.5.8 Olympus Corporation Covered Esophageal Stent SWOT Analysis
11.5.9 Olympus Corporation Recent Developments
11.6 ELLA-CS, s.r.o.
11.6.1 ELLA-CS, s.r.o. Corporation Information
11.6.2 ELLA-CS, s.r.o. Business Overview
11.6.3 ELLA-CS, s.r.o. Covered Esophageal Stent Product Models, Descriptions and Specifications
11.6.4 ELLA-CS, s.r.o. Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 ELLA-CS, s.r.o. Recent Developments
11.7 ENDO-FLEX GmbH
11.7.1 ENDO-FLEX GmbH Corporation Information
11.7.2 ENDO-FLEX GmbH Business Overview
11.7.3 ENDO-FLEX GmbH Covered Esophageal Stent Product Models, Descriptions and Specifications
11.7.4 ENDO-FLEX GmbH Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 ENDO-FLEX GmbH Recent Developments
11.8 Leufen Medical
11.8.1 Leufen Medical Corporation Information
11.8.2 Leufen Medical Business Overview
11.8.3 Leufen Medical Covered Esophageal Stent Product Models, Descriptions and Specifications
11.8.4 Leufen Medical Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Leufen Medical Recent Developments
11.9 Micro-Tech Endoscopy
11.9.1 Micro-Tech Endoscopy Corporation Information
11.9.2 Micro-Tech Endoscopy Business Overview
11.9.3 Micro-Tech Endoscopy Covered Esophageal Stent Product Models, Descriptions and Specifications
11.9.4 Micro-Tech Endoscopy Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Micro-Tech Endoscopy Recent Developments
11.10 Anrei medical (hz)
11.10.1 Anrei medical (hz) Corporation Information
11.10.2 Anrei medical (hz) Business Overview
11.10.3 Anrei medical (hz) Covered Esophageal Stent Product Models, Descriptions and Specifications
11.10.4 Anrei medical (hz) Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Anrei medical (hz) Recent Developments
11.11 Mitra Industries Private Limited
11.11.1 Mitra Industries Private Limited Corporation Information
11.11.2 Mitra Industries Private Limited Business Overview
11.11.3 Mitra Industries Private Limited Covered Esophageal Stent Product Models, Descriptions and Specifications
11.11.4 Mitra Industries Private Limited Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Mitra Industries Private Limited Recent Developments
11.12 Sewoon Medical
11.12.1 Sewoon Medical Corporation Information
11.12.2 Sewoon Medical Business Overview
11.12.3 Sewoon Medical Covered Esophageal Stent Product Models, Descriptions and Specifications
11.12.4 Sewoon Medical Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Sewoon Medical Recent Developments
11.13 INVAMED
11.13.1 INVAMED Corporation Information
11.13.2 INVAMED Business Overview
11.13.3 INVAMED Covered Esophageal Stent Product Models, Descriptions and Specifications
11.13.4 INVAMED Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 INVAMED Recent Developments
11.14 Jiangsu Vedkang Medical Science and Technology
11.14.1 Jiangsu Vedkang Medical Science and Technology Corporation Information
11.14.2 Jiangsu Vedkang Medical Science and Technology Business Overview
11.14.3 Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Product Models, Descriptions and Specifications
11.14.4 Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Jiangsu Vedkang Medical Science and Technology Recent Developments
11.15 Changzhou Zhiye Medical Instrument Research Institute
11.15.1 Changzhou Zhiye Medical Instrument Research Institute Corporation Information
11.15.2 Changzhou Zhiye Medical Instrument Research Institute Business Overview
11.15.3 Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Product Models, Descriptions and Specifications
11.15.4 Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Changzhou Zhiye Medical Instrument Research Institute Recent Developments
11.16 AndraTec
11.16.1 AndraTec Corporation Information
11.16.2 AndraTec Business Overview
11.16.3 AndraTec Covered Esophageal Stent Product Models, Descriptions and Specifications
11.16.4 AndraTec Covered Esophageal Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 AndraTec Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Covered Esophageal Stent Industry Chain
12.2 Covered Esophageal Stent Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Covered Esophageal Stent Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Covered Esophageal Stent Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Covered Esophageal Stent Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Covered Esophageal Stent Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Covered Esophageal Stent Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Covered Esophageal Stent Market Size Growth Rate by External Structure, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Covered Esophageal Stent Market Size Growth Rate by Diameter, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Covered Esophageal Stent Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Covered Esophageal Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Covered Esophageal Stent Revenue by Region (US$ Million), 2021-2026
Table 7. Global Covered Esophageal Stent Revenue by Region (US$ Million), 2027-2032
Table 8. Global Covered Esophageal Stent Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Covered Esophageal Stent Sales by Region (K Units), 2021-2026
Table 10. Global Covered Esophageal Stent Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Covered Esophageal Stent Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Covered Esophageal Stent Sales Share by Manufacturers (2021-2026)
Table 14. Global Covered Esophageal Stent Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Covered Esophageal Stent Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Covered Esophageal Stent Revenue, 2025
Table 18. Global Covered Esophageal Stent Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Covered Esophageal Stent Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Covered Esophageal Stent Manufacturing Base and Headquarters
Table 21. Global Covered Esophageal Stent Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Covered Esophageal Stent Sales Volume by Type (K Units), 2021-2026
Table 25. Global Covered Esophageal Stent Sales Volume by Type (K Units), 2027-2032
Table 26. Global Covered Esophageal Stent Revenue by Type (US$ Million), 2021-2026
Table 27. Global Covered Esophageal Stent Revenue by Type (US$ Million), 2027-2032
Table 28. Global Covered Esophageal Stent Sales Volume by External Structure (K Units), 2021-2026
Table 29. Global Covered Esophageal Stent Sales Volume by External Structure (K Units), 2027-2032
Table 30. Global Covered Esophageal Stent Revenue by External Structure (US$ Million), 2021-2026
Table 31. Global Covered Esophageal Stent Revenue by External Structure (US$ Million), 2027-2032
Table 32. Global Covered Esophageal Stent Sales Volume by Diameter (K Units), 2021-2026
Table 33. Global Covered Esophageal Stent Sales Volume by Diameter (K Units), 2027-2032
Table 34. Global Covered Esophageal Stent Revenue by Diameter (US$ Million), 2021-2026
Table 35. Global Covered Esophageal Stent Revenue by Diameter (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Covered Esophageal Stent Sales by Application (K Units), 2021-2026
Table 38. Global Covered Esophageal Stent Sales by Application (K Units), 2027-2032
Table 39. Covered Esophageal Stent High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Covered Esophageal Stent Revenue by Application (US$ Million), 2021-2026
Table 41. Global Covered Esophageal Stent Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Covered Esophageal Stent Growth Accelerators and Market Barriers
Table 45. North America Covered Esophageal Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Covered Esophageal Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Covered Esophageal Stent Growth Accelerators and Market Barriers
Table 48. Europe Covered Esophageal Stent Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Covered Esophageal Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Covered Esophageal Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Covered Esophageal Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Covered Esophageal Stent Growth Accelerators and Market Barriers
Table 53. Southeast Asia Covered Esophageal Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Covered Esophageal Stent Investment Opportunities and Key Challenges
Table 55. Central and South America Covered Esophageal Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Covered Esophageal Stent Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Covered Esophageal Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Boston Scientific Corporation Information
Table 59. Boston Scientific Description and Major Businesses
Table 60. Boston Scientific Product Models, Descriptions and Specifications
Table 61. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Boston Scientific Sales Value Proportion by Product in 2025
Table 63. Boston Scientific Sales Value Proportion by Application in 2025
Table 64. Boston Scientific Sales Value Proportion by Geographic Area in 2025
Table 65. Boston Scientific Covered Esophageal Stent SWOT Analysis
Table 66. Boston Scientific Recent Developments
Table 67. Cook Medical Corporation Information
Table 68. Cook Medical Description and Major Businesses
Table 69. Cook Medical Product Models, Descriptions and Specifications
Table 70. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Cook Medical Sales Value Proportion by Product in 2025
Table 72. Cook Medical Sales Value Proportion by Application in 2025
Table 73. Cook Medical Sales Value Proportion by Geographic Area in 2025
Table 74. Cook Medical Covered Esophageal Stent SWOT Analysis
Table 75. Cook Medical Recent Developments
Table 76. M.I.Tech Corporation Information
Table 77. M.I.Tech Description and Major Businesses
Table 78. M.I.Tech Product Models, Descriptions and Specifications
Table 79. M.I.Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. M.I.Tech Sales Value Proportion by Product in 2025
Table 81. M.I.Tech Sales Value Proportion by Application in 2025
Table 82. M.I.Tech Sales Value Proportion by Geographic Area in 2025
Table 83. M.I.Tech Covered Esophageal Stent SWOT Analysis
Table 84. M.I.Tech Recent Developments
Table 85. Merit Medical Systems Corporation Information
Table 86. Merit Medical Systems Description and Major Businesses
Table 87. Merit Medical Systems Product Models, Descriptions and Specifications
Table 88. Merit Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Merit Medical Systems Sales Value Proportion by Product in 2025
Table 90. Merit Medical Systems Sales Value Proportion by Application in 2025
Table 91. Merit Medical Systems Sales Value Proportion by Geographic Area in 2025
Table 92. Merit Medical Systems Covered Esophageal Stent SWOT Analysis
Table 93. Merit Medical Systems Recent Developments
Table 94. Olympus Corporation Corporation Information
Table 95. Olympus Corporation Description and Major Businesses
Table 96. Olympus Corporation Product Models, Descriptions and Specifications
Table 97. Olympus Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Olympus Corporation Sales Value Proportion by Product in 2025
Table 99. Olympus Corporation Sales Value Proportion by Application in 2025
Table 100. Olympus Corporation Sales Value Proportion by Geographic Area in 2025
Table 101. Olympus Corporation Covered Esophageal Stent SWOT Analysis
Table 102. Olympus Corporation Recent Developments
Table 103. ELLA-CS, s.r.o. Corporation Information
Table 104. ELLA-CS, s.r.o. Description and Major Businesses
Table 105. ELLA-CS, s.r.o. Product Models, Descriptions and Specifications
Table 106. ELLA-CS, s.r.o. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. ELLA-CS, s.r.o. Recent Developments
Table 108. ENDO-FLEX GmbH Corporation Information
Table 109. ENDO-FLEX GmbH Description and Major Businesses
Table 110. ENDO-FLEX GmbH Product Models, Descriptions and Specifications
Table 111. ENDO-FLEX GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. ENDO-FLEX GmbH Recent Developments
Table 113. Leufen Medical Corporation Information
Table 114. Leufen Medical Description and Major Businesses
Table 115. Leufen Medical Product Models, Descriptions and Specifications
Table 116. Leufen Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Leufen Medical Recent Developments
Table 118. Micro-Tech Endoscopy Corporation Information
Table 119. Micro-Tech Endoscopy Description and Major Businesses
Table 120. Micro-Tech Endoscopy Product Models, Descriptions and Specifications
Table 121. Micro-Tech Endoscopy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Micro-Tech Endoscopy Recent Developments
Table 123. Anrei medical (hz) Corporation Information
Table 124. Anrei medical (hz) Description and Major Businesses
Table 125. Anrei medical (hz) Product Models, Descriptions and Specifications
Table 126. Anrei medical (hz) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Anrei medical (hz) Recent Developments
Table 128. Mitra Industries Private Limited Corporation Information
Table 129. Mitra Industries Private Limited Description and Major Businesses
Table 130. Mitra Industries Private Limited Product Models, Descriptions and Specifications
Table 131. Mitra Industries Private Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Mitra Industries Private Limited Recent Developments
Table 133. Sewoon Medical Corporation Information
Table 134. Sewoon Medical Description and Major Businesses
Table 135. Sewoon Medical Product Models, Descriptions and Specifications
Table 136. Sewoon Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Sewoon Medical Recent Developments
Table 138. INVAMED Corporation Information
Table 139. INVAMED Description and Major Businesses
Table 140. INVAMED Product Models, Descriptions and Specifications
Table 141. INVAMED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. INVAMED Recent Developments
Table 143. Jiangsu Vedkang Medical Science and Technology Corporation Information
Table 144. Jiangsu Vedkang Medical Science and Technology Description and Major Businesses
Table 145. Jiangsu Vedkang Medical Science and Technology Product Models, Descriptions and Specifications
Table 146. Jiangsu Vedkang Medical Science and Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Jiangsu Vedkang Medical Science and Technology Recent Developments
Table 148. Changzhou Zhiye Medical Instrument Research Institute Corporation Information
Table 149. Changzhou Zhiye Medical Instrument Research Institute Description and Major Businesses
Table 150. Changzhou Zhiye Medical Instrument Research Institute Product Models, Descriptions and Specifications
Table 151. Changzhou Zhiye Medical Instrument Research Institute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Changzhou Zhiye Medical Instrument Research Institute Recent Developments
Table 153. AndraTec Corporation Information
Table 154. AndraTec Description and Major Businesses
Table 155. AndraTec Product Models, Descriptions and Specifications
Table 156. AndraTec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. AndraTec Recent Developments
Table 158. Key Raw Materials Distribution
Table 159. Raw Materials Key Suppliers
Table 160. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 161. Milestones in Production Technology Evolution
Table 162. Distributors List
Table 163. Market Trends and Market Evolution
Table 164. Market Drivers and Opportunities
Table 165. Market Challenges, Risks, and Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources

List of Figures
Figure 1. Covered Esophageal Stent Product Picture
Figure 2. Global Covered Esophageal Stent Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Fully Covered Esophageal Stent Product Picture
Figure 4. Partially Covered Esophageal Stent Product Picture
Figure 5. Global Covered Esophageal Stent Market Size Growth Rate by External Structure, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Double Cup Mouth Cylindrical Mesh Product Picture
Figure 7. Cup Mouth Ball Head Cylindrical Mesh Product Picture
Figure 8. Global Covered Esophageal Stent Market Size Growth Rate by Diameter, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Diameter 16 mm Product Picture
Figure 10. Diameter 18 mm Product Picture
Figure 11. Diameter 20 mm Product Picture
Figure 12. Diameter 22 mm Product Picture
Figure 13. Diameter 25 mm Product Picture
Figure 14. Global Covered Esophageal Stent Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Malignant Esophageal Stricture
Figure 16. Benign Esophageal Stricture
Figure 17. Esophageal Fistula and Perforation
Figure 18. Other
Figure 19. Covered Esophageal Stent Report Years Considered
Figure 20. Global Covered Esophageal Stent Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 22. Global Covered Esophageal Stent Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 23. Global Covered Esophageal Stent Revenue-Based Market Share by Region (2021-2032)
Figure 24. Global Covered Esophageal Stent Sales (K Units), 2021-2032
Figure 25. Global Covered Esophageal Stent Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 26. Global Covered Esophageal Stent Sales Market Share by Region (2021-2032)
Figure 27. Top 5 and Top 10 Manufacturers Covered Esophageal Stent Sales Volume Market Share in 2025
Figure 28. Global Covered Esophageal Stent Revenue-Based Market Share Ranking (2025)
Figure 29. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 30. Fully Covered Esophageal Stent Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Partially Covered Esophageal Stent Revenue-Based Market Share by Manufacturer in 2025
Figure 32. Global Covered Esophageal Stent Sales Volume-Based Market Share by Type (2021-2032)
Figure 33. Global Covered Esophageal Stent Revenue-Based Market Share by Type (2021-2032)
Figure 34. Global Covered Esophageal Stent ASP by Type (US$/Unit), 2021-2032
Figure 35. Global Covered Esophageal Stent Sales Volume-Based Market Share by External Structure (2021-2032)
Figure 36. Global Covered Esophageal Stent Revenue-Based Market Share by External Structure (2021-2032)
Figure 37. Global Covered Esophageal Stent ASP by External Structure (US$/Unit), 2021-2032
Figure 38. Global Covered Esophageal Stent Sales Volume-Based Market Share by Diameter (2021-2032)
Figure 39. Global Covered Esophageal Stent Revenue-Based Market Share by Diameter (2021-2032)
Figure 40. Global Covered Esophageal Stent ASP by Diameter (US$/Unit), 2021-2032
Figure 41. Global Covered Esophageal Stent Sales Market Share by Application (2021-2032)
Figure 42. Global Covered Esophageal Stent Revenue-Based Market Share by Application (2021-2032)
Figure 43. Global Covered Esophageal Stent ASP by Application (US$/Unit), 2021-2032
Figure 44. North America Covered Esophageal Stent Sales YoY (K Units), 2021-2032
Figure 45. North America Covered Esophageal Stent Revenue YoY (US$ Million), 2021-2032
Figure 46. North America Top 5 Manufacturers Covered Esophageal Stent Sales Revenue (US$ Million) in 2025
Figure 47. North America Covered Esophageal Stent Sales Volume (K Units) by Application (2021-2032)
Figure 48. North America Covered Esophageal Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 49. US Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 50. Canada Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 51. Mexico Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 52. Europe Covered Esophageal Stent Sales YoY (K Units), 2021-2032
Figure 53. Europe Covered Esophageal Stent Revenue YoY (US$ Million), 2021-2032
Figure 54. Europe Top 5 Manufacturers Covered Esophageal Stent Sales Revenue (US$ Million) in 2025
Figure 55. Europe Covered Esophageal Stent Sales Volume (K Units) by Application (2021-2032)
Figure 56. Europe Covered Esophageal Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 57. Germany Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 58. France Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 59. U.K. Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 60. Italy Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 61. Russia Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 62. Asia-Pacific Covered Esophageal Stent Sales YoY (K Units), 2021-2032
Figure 63. Asia-Pacific Covered Esophageal Stent Revenue YoY (US$ Million), 2021-2032
Figure 64. Asia-Pacific Top 8 Manufacturers Covered Esophageal Stent Sales Revenue (US$ Million) in 2025
Figure 65. Asia-Pacific Covered Esophageal Stent Sales Volume (K Units) by Application (2021-2032)
Figure 66. Asia-Pacific Covered Esophageal Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 67. Indonesia Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 68. Japan Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 69. South Korea Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 70. China Taiwan Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 71. India Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 72. Central and South America Covered Esophageal Stent Sales YoY (K Units), 2021-2032
Figure 73. Central and South America Covered Esophageal Stent Revenue YoY (US$ Million), 2021-2032
Figure 74. Central and South America Top 5 Manufacturers Covered Esophageal Stent Sales Revenue (US$ Million) in 2025
Figure 75. Central and South America Covered Esophageal Stent Sales Volume (K Units) by Application (2021-2032)
Figure 76. Central and South America Covered Esophageal Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 77. Brazil Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 78. Argentina Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 79. Middle East, and Africa Covered Esophageal Stent Sales YoY (K Units), 2021-2032
Figure 80. Middle East and Africa Covered Esophageal Stent Revenue YoY (US$ Million), 2021-2032
Figure 81. Middle East and Africa Top 5 Manufacturers Covered Esophageal Stent Sales Revenue (US$ Million) in 2025
Figure 82. Middle East and Africa Covered Esophageal Stent Sales Volume (K Units) by Application (2021-2032)
Figure 83. Middle East and Africa Covered Esophageal Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 84. GCC Countries Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 85. Turkey Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 86. Egypt Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 87. South Africa Covered Esophageal Stent Revenue (US$ Million), 2021-2032
Figure 88. Covered Esophageal Stent Industry Chain Mapping
Figure 89. Regional Covered Esophageal Stent Manufacturing Base Distribution (%)
Figure 90. Global Covered Esophageal Stent Production Market Share by Region (2021-2032)
Figure 91. Covered Esophageal Stent Production Process
Figure 92. Regional Covered Esophageal Stent Production Cost Structure
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed